AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2018
Sep 11, 2018
29821_dirs_2018-09-11_14376556-068d-41e4-9d4f-c2a1e6eac9aa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2018-09-10
Reporting Person: Wang Xin Warren (SVP and Pres, Asia Pacific)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-09-10 | Common Stock | S | 10000.0000 | $35.8595 | Disposed | 92162.0000 | Direct |
Footnotes
F1: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $35.71 to $36.02, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.